CWA Asset Management Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

CWA Asset Management Group’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.22M	Buy	+290,366	New	+$1.12M	0.04%	367

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

CWA Asset Management Group's IRWD Position: Q2 2026 in Review

CWA Asset Management Group opened a new position in Ironwood Pharmaceuticals (IRWD) in Q2 2026: 290,366 shares worth $1.22M. The stake represents 0.04% of the portfolio and ranks #367 among its holdings.

212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

CWA Asset Management Group held 290,366 shares of Ironwood Pharmaceuticals worth $1.22M as of Q2 2026.
Ironwood Pharmaceuticals was a new CWA Asset Management Group position in Q2 2026.
Ironwood Pharmaceuticals made up 0.04% of CWA Asset Management Group's portfolio in Q2 2026, its #367 holding.
212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.